Clinical observation on the treatment of polycystic ovarian syndrome with added Qudu-Tongyang decoction of Zhuang medicine
Objective:To observe the clinical efficacy of added Qudu-Tongyang decoction of Zhuang medicine in the treatment of patients with polycystic ovarian syndrome(PCOS).Methods:A total of 62 PCOS patients were randomly divided into the observation group and the control group,with 31 cases in each group.The control group was treated with Ethinylestradiol-cyproterone acetate and metformin hydrochloride tablets,while the observation group received Qudu-Tongyang decoction of Zhuang medicine on the basis of that of the control group.Both groups were treated for 3 menstrual cycles.The main efficacy evaluation indicators included menstrual status scores,bilateral ovarian volume,sex hormones[testosterone(T),luteinizing hormone(LH),follicle stimulating hormone(FSH)]levels,fasting insulin(FINS),fasting blood glucose(FBG)levels,and HOMA insulin resistance(HOMA-IR),which were compared between the two groups before and after the treatment.Results:Following the treatment,both groups of patients experienced re-ductions in menstrual status scores,sex hormones(FSH,LH,and T)levels,blood glucose metabolism index(FINS,FPG,and HOMA-IR),and bilateral ovarian volumes.The degree of reduction in the observation group was significantly bet-ter than that in the control group(P<0.05 or P<0.01).Conclusion:Added Qudu-Tongyang decoction of Zhuang medi-cine with Ethinylestradiol-cyproterone acetate and metformin hydrochloride tablets for polycystic ovarian syndrome can effectively improve the menstrual status and sex hormones levels,reduce ovarian volume,correct endocrine meta-bolic disorders,and alleviate clinical symptoms.
polycystic ovarian syndrome(PCOS)Qudu-Tongyang decoction of Zhuang medicinetherapy of Zhuang medicine
NETL
NSTL
万方数据
